A $250 Biohack That’s Revolutionizing Life with Diabetes
The article, strangely, leaves out the name of the project it&#x27;s reporting on. It&#x27;s OpenAPS, <a href="http:&#x2F;&#x2F;openaps.readthedocs.io&#x2F;en&#x2F;latest&#x2F;" rel="nofollow">http:&#x2F;&#x2F;openaps.readthedocs.io&#x2F;en&#x2F;latest&#x2F;</a> . I use it and have worked on the code. It&#x27;s a <i>massive</i> health and quality of life improvement over anything that exists which is FDA approved. The core problem is that the FDA-approved devices are optimized not for getting the best result, but for ensuring the manufacturer can&#x27;t be blamed if something goes wrong. But that in practice means kicking most of the important things to the end user and their physician, who can&#x27;t do nearly as good a job as software can.